#Whitewine

A recent international meta-analysis has shaken perceptions about wine and health, revealing that white wine—long believed by some to be a “lighter,” lower-risk alcohol choice—may increase the risk of skin cancer, particularly for women. While both red and white wine are forms of alcohol known to elevate cancer risk overall, white wine has now been shown to carry specific risks that have not been widely recognized, according to a sweeping 2025 review by scientists at Brown University and corroborated by several other reputable research institutions (Brown University report, MDPI meta-analysis, News-Medical).

A comprehensive meta-analysis released in 2025 challenges the idea that white wine is a safer, lighter alcohol choice. Researchers from Brown University, supported by other respected institutions, found that white wine is associated with a higher risk of skin cancer, especially among women. The study combined data from 42 studies with about 96,000 participants and showed a 22% increase in skin cancer risk for white wine drinkers, while red wine did not show a significant protective effect. Among women, white wine was linked to a 26% higher overall cancer risk. This research marks the most thorough examination to date of how wine type may influence cancer risk, undermining the notion that white wine is benign.